REPORT ID 428

United States Liquid Embolics Market Report 2017

Publish Date
01-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the United States Liquid Embolics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Liquid Embolics in these regions, from 2012 to 2022 (forecast).

United States Liquid Embolics market competition by top manufacturers/players, with Liquid Embolics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Medtronic
    Boston Scientific
    St. Jude Medical
    Cyberonics
    Codman & Shurtleff
    Stryker
    Integra LifeSciences
    InoMed
    Mizuho America
    RauMedic

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Isobutyl-2-Cyanoacrylate(IBCA)
    Ethanol
    Sodium Morrhuate
    Bletilla Striata
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Tumor and Brain Cancer
    Brain Arteriovenous Malformations
    Ischemic Stroke
    Brain Aneurysm
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Liquid Embolics Market Report 2017
1 Liquid Embolics Overview
    1.1 Product Overview and Scope of Liquid Embolics
    1.2 Classification of Liquid Embolics by Product Category
        1.2.1 United States Liquid Embolics Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Liquid Embolics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Isobutyl-2-Cyanoacrylate(IBCA)
        1.2.4 Ethanol
        1.2.5 Sodium Morrhuate
        1.2.6 Bletilla Striata
        1.2.7 Others
    1.3 United States Liquid Embolics Market by Application/End Users
        1.3.1 United States Liquid Embolics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Tumor and Brain Cancer
        1.3.3 Brain Arteriovenous Malformations
        1.3.4 Ischemic Stroke
        1.3.5 Brain Aneurysm
        1.3.6 Others
    1.4 United States Liquid Embolics Market by Region
        1.4.1 United States Liquid Embolics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Liquid Embolics Status and Prospect (2012-2022)
        1.4.3 Southwest Liquid Embolics Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Liquid Embolics Status and Prospect (2012-2022)
        1.4.5 New England Liquid Embolics Status and Prospect (2012-2022)
        1.4.6 The South Liquid Embolics Status and Prospect (2012-2022)
        1.4.7 The Midwest Liquid Embolics Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Liquid Embolics (2012-2022)
        1.5.1 United States Liquid Embolics Sales and Growth Rate (2012-2022)
        1.5.2 United States Liquid Embolics Revenue and Growth Rate (2012-2022)

2 United States Liquid Embolics Market Competition by Players/Suppliers
    2.1 United States Liquid Embolics Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Liquid Embolics Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Liquid Embolics Average Price by Players/Suppliers (2012-2017)
    2.4 United States Liquid Embolics Market Competitive Situation and Trends
        2.4.1 United States Liquid Embolics Market Concentration Rate
        2.4.2 United States Liquid Embolics Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Liquid Embolics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Liquid Embolics Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Liquid Embolics Sales and Market Share by Region (2012-2017)
    3.2 United States Liquid Embolics Revenue and Market Share by Region (2012-2017)
    3.3 United States Liquid Embolics Price by Region (2012-2017)

4 United States Liquid Embolics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Liquid Embolics Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Liquid Embolics Revenue and Market Share by Type (2012-2017)
    4.3 United States Liquid Embolics Price by Type (2012-2017)
    4.4 United States Liquid Embolics Sales Growth Rate by Type (2012-2017)

5 United States Liquid Embolics Sales (Volume) by Application (2012-2017)
    5.1 United States Liquid Embolics Sales and Market Share by Application (2012-2017)
    5.2 United States Liquid Embolics Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Liquid Embolics Players/Suppliers Profiles and Sales Data
    6.1 Medtronic
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Liquid Embolics Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Medtronic Liquid Embolics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boston Scientific
        6.2.2 Liquid Embolics Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boston Scientific Liquid Embolics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 St. Jude Medical
        6.3.2 Liquid Embolics Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 St. Jude Medical Liquid Embolics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Cyberonics
        6.4.2 Liquid Embolics Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Cyberonics Liquid Embolics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Codman & Shurtleff
        6.5.2 Liquid Embolics Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Codman & Shurtleff Liquid Embolics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Stryker
        6.6.2 Liquid Embolics Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Stryker Liquid Embolics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Integra LifeSciences
        6.7.2 Liquid Embolics Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Integra LifeSciences Liquid Embolics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 InoMed
        6.8.2 Liquid Embolics Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 InoMed Liquid Embolics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Mizuho America
        6.9.2 Liquid Embolics Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Mizuho America Liquid Embolics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 RauMedic
        6.10.2 Liquid Embolics Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 RauMedic Liquid Embolics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Liquid Embolics Manufacturing Cost Analysis
    7.1 Liquid Embolics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Liquid Embolics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Liquid Embolics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Liquid Embolics Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Liquid Embolics Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Liquid Embolics Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Liquid Embolics Sales Volume Forecast by Type (2017-2022)
    11.3 United States Liquid Embolics Sales Volume Forecast by Application (2017-2022)
    11.4 United States Liquid Embolics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer